HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer

Taane G Clark, Douglas G Altman, Bianca L De Stavola, Quantification of the completeness of follow-up. The Lancet. ,vol. 359, pp. 1309- 1310 ,(2002) , 10.1016/S0140-6736(02)08272-7

Andrea Bertotti, Giorgia Migliardi, Francesco Galimi, Francesco Sassi, Davide Torti, Claudio Isella, Davide Corà, Federica Di Nicolantonio, Michela Buscarino, Consalvo Petti, Dario Ribero, Nadia Russolillo, Andrea Muratore, Paolo Massucco, Alberto Pisacane, Luca Molinaro, Emanuele Valtorta, Andrea Sartore-Bianchi, Mauro Risio, Lorenzo Capussotti, Marcello Gambacorta, Salvatore Siena, Enzo Medico, Anna Sapino, Silvia Marsoni, Paolo M Comoglio, Alberto Bardelli, Livio Trusolino, None, A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discovery. ,vol. 1, pp. 508- 523 ,(2011) , 10.1158/2159-8290.CD-11-0109

V Martin, L Landi, F Molinari, G Fountzilas, R Geva, A Riva, P Saletti, S De Dosso, A Spitale, S Tejpar, K T Kalogeras, L Mazzucchelli, M Frattini, F Cappuzzo, HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients British Journal of Cancer. ,vol. 108, pp. 668- 675 ,(2013) , 10.1038/BJC.2013.4

K. Yonesaka, K. Zejnullahu, I. Okamoto, T. Satoh, F. Cappuzzo, J. Souglakos, D. Ercan, A. Rogers, M. Roncalli, M. Takeda, Y. Fujisaka, J. Philips, T. Shimizu, O. Maenishi, Y. Cho, J. Sun, A. Destro, K. Taira, K. Takeda, T. Okabe, J. Swanson, H. Itoh, M. Takada, E. Lifshits, K. Okuno, J. A. Engelman, R. A. Shivdasani, K. Nishio, M. Fukuoka, M. Varella-Garcia, K. Nakagawa, P. A. Janne, Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3002442

B Ingold Heppner, H-M Behrens, K Balschun, J Haag, S Krüger, T Becker, C Röcken, HER2/neu testing in primary colorectal carcinoma British Journal of Cancer. ,vol. 111, pp. 1977- 1984 ,(2014) , 10.1038/BJC.2014.483

Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh, Giuseppe Aprile, Evgeny Kulikov, Julie Hill, Michaela Lehle, Josef Rüschoff, Yoon-Koo Kang, None, Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial The Lancet. ,vol. 376, pp. 687- 697 ,(2010) , 10.1016/S0140-6736(10)61121-X

E. Missiaglia, B. Jacobs, G. D'Ario, A.F. Di Narzo, C. Soneson, E. Budinska, V. Popovici, L. Vecchione, S. Gerster, P. Yan, A.D. Roth, D. Klingbiel, F.T. Bosman, M. Delorenzi, S. Tejpar, Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features Annals of Oncology. ,vol. 25, pp. 1995- 2001 ,(2014) , 10.1093/ANNONC/MDU275

Susan D Richman, Katie Southward, Philip Chambers, Debra Cross, Jennifer Barrett, Gemma Hemmings, Morag Taylor, Henry Wood, Gordon Hutchins, Joseph M Foster, Assa Oumie, Karen G Spink, Sarah R Brown, Marc Jones, David Kerr, Kelly Handley, Richard Gray, Matthew Seymour, Philip Quirke, HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials. The Journal of Pathology. ,vol. 238, pp. 562- 570 ,(2016) , 10.1002/PATH.4679

Donna M Muzny, Matthew N Bainbridge, Kyle Chang, Huyen H Dinh, Jennifer A Drummond, Gerald Fowler, Christie L Kovar, Lora R Lewis, Margaret B Morgan, Irene F Newsham, Jeffrey G Reid, Jireh Santibanez, Eve Shinbrot, Lisa R Trevino, Yuan-Qing Wu, Min Wang, Preethi Gunaratne, Lawrence A Donehower, Chad J Creighton, David A Wheeler, Richard A Gibbs, Michael S Lawrence, Douglas Voet, Rui Jing, Kristian Cibulskis, Andrey Sivachenko, Petar Stojanov, Aaron McKenna, Eric S Lander, Stacey Gabriel, Gad Getz, Li Ding, Robert S Fulton, Daniel C Koboldt, Todd Wylie, Jason Walker, David J Dooling, Lucinda Fulton, Kim D Delehaunty, Catrina C Fronick, Ryan Demeter, Elaine R Mardis, Richard K Wilson, Andy Chu, Hye-Jung E Chun, Andrew J Mungall, Erin Pleasance, A Gordon Robertson, Dominik Stoll, Miruna Balasundaram, Inanc Birol, Yaron SN Butterfield, Eric Chuah, Robin JN Coope, Noreen Dhalla, Ranabir Guin, Carrie Hirst, Martin Hirst, Robert A Holt, Darlene Lee, Haiyan I Li, Michael Mayo, Richard A Moore, Jacqueline E Schein, Jared R Slobodan, Angela Tam, Nina Thiessen, Richard Varhol, Thomas Zeng, Yongjun Zhao, Steven JM Jones, Marco A Marra, Adam J Bass, Alex H Ramos, Gordon Saksena, Andrew D Cherniack, Stephen E Schumacher, Barbara Tabak, Scott L Carter, Nam H Pho, Huy Nguyen, Robert C Onofrio, Andrew Crenshaw, Kristin Ardlie, Rameen Beroukhim, Wendy Winckler, Matthew Meyerson, Alexei Protopopov, Juinhua Zhang, Angela Hadjipanayis, Eunjung Lee, Ruibin Xi, Lixing Yang, Xiaojia Ren, Hailei Zhang, Narayanan Sathiamoorthy, Sachet Shukla, Peng-Chieh Chen, Psalm Haseley, Yonghong Xiao, Semin Lee, Jonathan Seidman, Lynda Chin, Peter J Park, Raju Kucherlapati, J Todd Auman, Katherine A Hoadley, Ying Du, Matthew D Wilkerson, Yan Shi, Christina Liquori, Shaowu Meng, Ling Li, Yidi J Turman, Michael D Topal, Donghui Tan, Scot Waring, Elizabeth Buda, Jesse Walsh, Corbin D Jones, Piotr A Mieczkowski, Darshan Singh, Junyuan Wu, Anisha Gulabani, Peter Dolina, Tom Bodenheimer, Alan P Hoyle, Janae V Simons, Matthew Soloway, Lisle E Mose, Stuart R Jefferys, Saianand Balu, Brian D O’Connor, Jan F Prins, Derek Y Chiang, D Neil Hayes, Charles M Perou, Toshinori Hinoue, Daniel J Weisenberger, Dennis T Maglinte, Fei Pan, Benjamin P Berman, David J Van Den Berg, Hui Shen, Timothy Triche Jr, Stephen B Baylin, Peter W Laird, Michael Noble, Doug Voet, Nils Gehlenborg, Comprehensive molecular characterization of human colon and rectal cancer Nature. ,vol. 487, pp. 330- 337 ,(2012) , 10.1038/NATURE11252

Soo Kyung Nam, Sumi Yun, Jiwon Koh, Yoonjin Kwak, An Na Seo, Kyoung Un Park, Duck-Woo Kim, Sung-Bum Kang, Woo Ho Kim, Hye Seung Lee, BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis PLOS ONE. ,vol. 11, ,(2016) , 10.1371/JOURNAL.PONE.0151865